Our industry-recognized Education team is committed to sharing program findings, best practices, insights, and trends from our educational programs across a range of therapeutic areas. These findings are regularly published in peer-reviewed journals, as well as presented at medical, patient, and industry conferences.
Poster Presentation The Power of Education to Debunk Myths and Misconceptions about Clinical Trial Participation Among People with Diverse Racial and Ethnic Backgrounds The 2022 Alliance Industry Summit (ASI) will feature our poster about the power of education to debunk myths and misconceptions about clinical trial participation among people from...
Aligned Education Improves Patient Outcomes Across CME Programs The American Academy of Neurology's Annual Conference kicks off on April 2, 2022 in Seattle, featuring exclusive neurology science and education. We're pleased to share that PlatformQ Health has three posters published at the event, highlighting the outcomes of three aligned patient/provider...
Immune checkpoint inhibitors have brought tailored treatments for patients with a variety of cancers. This is changing the face of treatment and the practice patterns clinicians have for everything from diagnosis to testing, adverse event management, and survivorship care. To help clinicians prepare for these changes, PlatformQ Health and the...
Advances in disease-modifying therapies for multiple sclerosis can improve the quality of life of patients - yet rapid changes to the treatment landscape left knowledge gaps among providers and patients. In addition, for patients to play a role in their own making, they also need to understand treatment options, side...
Emerging treatments such as anti-GD2 therapies are improving outcomes for children with relapsed/refractory, high-risk neuroblastoma. The changing therapeutic landscape has left knowledge gaps, with clinicians needing assistance with understanding how to integrate new agents, administer new treatments, and manage associated side effects. To address these issues, PlatformQ Health teamed up...
For many people suffering from rare diseases, the diagnostic odyssey is far too long. Nearly 1 in 13 people are living with an undiagnosed condition, and it typically takes five years or longer to receive the correct diagnosis. Consistent clinician and patient education about rare diseases is crucial for helping...
The Accreditation Council for Continuing Medical Education reports that approximately 1,680 accredited education providers offered more than 170,000 educational activities in the past year alone, yet many providers lack the ability to track the effectiveness of the programs. Assessing the actual outcomes of continuing medical education (CME) is essential. That...
The pandemic has left clinicians who offer anti-VEGF therapy challenged to incorporate new procedures into clinical practice amid the need to add screening strategies to reduce transmission risk. To support U.S. retinal specialists and ophthalmologists who deliver anti-VEGF therapy to patients with diabetic retinopathy, diabetic macular edema, neovascular age-related macular...
Heart disease remains a major cause of morbidity, hospitalizations, and mortality, particularly in women. Women experience a higher symptom burden than men, are more frequently misdiagnosed, and are underrepresented in clinical trials for health failure treatment. To address these gaps, PlatformQ Health and the American Society for Preventive Cardiology launched...
Early diagnosis and intervention is crucial for improving the quality of life of patients with Duchenne Muscular Dystrophy. However, emerging guidelines and therapeutic advances have brought about competency gaps in understanding mutation-specific treatments and more. To address these gaps, PlatformQ Health, Parent Project Muscular Dystrophy, and the National Organization of...
Biomarker testing and new therapies are reshaping care of certain types of cancer. Yet many clinicians report a lack of awareness about and experience with such options. To address these barriers, Large Urology Group Practice Association (LUGPA) and PlatformQ Health collaborated in the creation of two serial education programs for...
PlatformQ Health is pleased to announce the publication of a poster at the 2021 ASCO Annual Meeting. Incorporating HER2/HER3 Targeted Therapies Across Solid Tumors: Addressing the Impact of Digital Education on Clinician Practice Patterns shares insights from a multi-session CME activity, Getting to Know HER: An In-Depth Discussion on HER2/HER3-Targeted...